These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3745760)

  • 21. More on Transderm Scop patches.
    N Engl J Med; 1984 Nov; 311(21):1377-8. PubMed ID: 6493292
    [No Abstract]   [Full Text] [Related]  

  • 22. Antimotion-sickness efficacy of scopolamine 12 and 72 hours after transdermal administration.
    Graybiel A; Cramer DB; Wood CD
    Aviat Space Environ Med; 1982 Aug; 53(8):770-2. PubMed ID: 7181807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal scopolamine, oral meclizine, and placebo in motion sickness.
    Dahl E; Offer-Ohlsen D; Lillevold PE; Sandvik L
    Clin Pharmacol Ther; 1984 Jul; 36(1):116-20. PubMed ID: 6734040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal scopolamine in the prevention of motion sickness at sea.
    Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G
    Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.
    Graybiel A; Cramer DB; Wood CD
    Aviat Space Environ Med; 1981 Jun; 52(6):337-9. PubMed ID: 7259691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histaminergic response to Coriolis stimulation: implication for transdermal scopolamine therapy of motion sickness.
    Wang ET; Zhou DR; He LH
    Aviat Space Environ Med; 1992 Jul; 63(7):579-82. PubMed ID: 1616432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What is your diagnosis? Unilateral mydriasis due to rubbing the eye with scopolamine].
    Kaeser HE
    Schweiz Rundsch Med Prax; 1992 Apr; 81(15):455-6. PubMed ID: 1565935
    [No Abstract]   [Full Text] [Related]  

  • 28. Scopolamine patch to prevent seasickness: clinical response vs. plasma concentration in sailors.
    Gil A; Nachum Z; Dachir S; Chapman S; Levy A; Shupak A; Adir Y; Tal D
    Aviat Space Environ Med; 2005 Aug; 76(8):766-70. PubMed ID: 16110693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing motion sickness.
    Hodgson T
    Can Med Assoc J; 1982 Jun; 126(12):1374. PubMed ID: 7083089
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
    Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG
    Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermally administered scopolamine.
    Paasuke RT
    CMAJ; 1985 Nov; 133(10):956. PubMed ID: 4063911
    [No Abstract]   [Full Text] [Related]  

  • 32. Unilateral mydriasis due to scopolamine patch.
    Vasselon P; Weiner L; Rossi-Pujo F; Socha M; Peton P; May I; Demore B; Javelot H
    Int J Clin Pharm; 2011 Oct; 33(5):737-9. PubMed ID: 21870093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of low-dose intranasal scopolamine for motion sickness.
    Simmons RG; Phillips JB; Lojewski RA; Wang Z; Boyd JL; Putcha L
    Aviat Space Environ Med; 2010 Apr; 81(4):405-12. PubMed ID: 20377145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. I heard that the adhesive patch you can wear to prevent motion sickness is available again. Why was it taken off the market?
    Mayo Clin Health Lett; 1998 Mar; 16(3):8. PubMed ID: 9516375
    [No Abstract]   [Full Text] [Related]  

  • 35. Scopoderm: transdermal hyoscine for motion sickness.
    Drug Ther Bull; 1989 Nov; 27(23):91-2. PubMed ID: 2519317
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of transdermal scopolamine against seasickness: a 3-day study at sea.
    Attias J; Gordon C; Ribak J; Binah O; Rolnick A
    Aviat Space Environ Med; 1987 Jan; 58(1):60-2. PubMed ID: 3814034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anisocoria after scopolamine transdermal patch contamination: A case report.
    Joo JH
    Medicine (Baltimore); 2021 Nov; 100(46):e27887. PubMed ID: 34797334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of transcutaneous scopolamine and depth on diver performance.
    Williams TH; Wilkinson AR; Davis FM; Frampton CM
    Undersea Biomed Res; 1988 Mar; 15(2):89-98. PubMed ID: 3363755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal scopolamine delivery system.
    Hirsch D
    Ann Ophthalmol; 1984 May; 16(5):406, 419. PubMed ID: 6742676
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of transdermal scopolamine upon psychological test performance at sea.
    Parrott AC; Jones R
    Eur J Clin Pharmacol; 1985; 28(4):419-23. PubMed ID: 4029247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.